Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 97Active not recruiting 9Unknown 6Terminated 6Recruiting 5Withdrawn 4Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 6NIH 3OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Spondylolisthesis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myasthenia Gravis 1Lymphoma, Follicular 1Localized Advanced Rectal Adenocarcinoma 1Head and Neck Neoplasms 1Digestive System Diseases 1

Interventions

Maintenance 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × NETWORK × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all
NCT06773936 2026-05-06

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

SWOG Cancer Research Network

Phase 2 Enrolling by invitation
55 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡